MAPK7 and hepatocellular carcinoma: An amplification of the region where ERK5 is located has been detected in approximately 50% of primary hepatocellular adenocarcinoma tumors24 and recently it has been shown that ERK5 modulates tumor development in this type of carcinoma16.